Breast Cancer Female Nos clinical trials

Explore recruiting breast cancer female nos clinical trials.

Recruiting breast cancer female nos studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Breast Cancer Female Nos trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

CHACRY-1501 : RISK OF INFERTILITY RELATED TO ADJUVANT CHEMOTHERAPY IN YOUNG BREAST CANCER PATIENTS: OOCYTE/EMBRYO CRYOPRESERVATION

France

Therapeutic exploratory (Phase II) EU CTIS Study details

DOSABEMA-Pharmacokinetic model of abemaciclib: correlation with severe diarrhea as the primary toxicity endpoint in patients with hormone receptor-positive localized breast cancer

France

Therapeutic use (Phase IV) EU CTIS Study details

PREDIX HER2 - Neoadjuvant response-guided treatment of HER2 positive breast cancer. Part of a platform of translational phase II trials based on molecular subtypes

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

First in human clinical trial to evaluate the safety, tolerability and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Breast Cancer Female Nos trials by city

Breast Cancer Female Nos in Toronto Breast Cancer Female Nos in Vancouver Breast Cancer Female Nos in Montreal Breast Cancer Female Nos in Calgary Breast Cancer Female Nos in Edmonton Breast Cancer Female Nos in Ottawa Breast Cancer Female Nos in Winnipeg Breast Cancer Female Nos in Quebec City Breast Cancer Female Nos in Hamilton Breast Cancer Female Nos in Kitchener Breast Cancer Female Nos in London Breast Cancer Female Nos in Halifax Breast Cancer Female Nos in New York Breast Cancer Female Nos in Los Angeles Breast Cancer Female Nos in Chicago Breast Cancer Female Nos in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease